Actelion's P2P Acquisition

Actelion raised a round of funding on June 16, 2017. Investors include Johnson & Johnson.

Actelion Pharmaceuticals is a biopharmaceutical company headquartered in Allschwil/Basel, Switzerland, focusing on the discovery, development and commercialization of innovative treatments to serve hi…

Articles about Actelion's P2P Acquisition: